Skip to main content
. 2021 Feb 12;13(2):600. doi: 10.3390/nu13020600

Table 1.

Comparison of main characteristics of included patients at the time of CD diagnosis with respect to presence or absence of persistent GI symptoms/malabsorption signs.

N (%) Patients with Persistent Sign/Symptoms
Group 1 n = 37
Patients without Persistent Signs/Symptoms
Group 2 n = 65
p
Median age at diagnosis, yrs (range) 41 (18–76) 38 (18–66) 0.245
Female gender (%) 28 (75.7) 45 (69.2) 0.648
Median BMI * Kg/m2 (range) 23.4 (17.5–31.8) 21.1 (16–30.8) 0.168
Comorbidities
Autoimmune 9 (24.3) 17 (26.5) 1
Others # 8 (18.8) 13 (20.3) 1
Family history of CD § 8 (21.6) 8 (12.3) 0.261
≥5 years of duration of symptoms/signs before CD diagnosis 13 (39.4) 10 (18.8) 0.045
H. pylori infection 10 (27%) 17 (26.1%) 1
Clinical presentation
Only GI ° symptoms 8 (21.6) 15 (23.1) 0.807
Only malabsorption signs 5 (13.5) 5 (7.7) 0.498
Both symptoms and signs 24(64.8) 45 (69.2) 0.665
GI symptoms
Total pts with GI symptoms 32 (86.5) 54 (83.1) 0.780
Nausea/vomiting 11 (29.7) 17 (26.1) 0.817
Heartburn 16 (43.2) 29 (44.6) 1
Regurgitation 7 (18.9) 14 (21.5) 0.804
Dysphagia 7 (18.9) 7 (10.7) 0.369
Postprandial fullness/early satiety 18 (48.6) 37 (56.9) 0.535
Abdominal pain 20 (54) 39 (60) 0.677
Abdominal bloating 23 (62.2) 48 (73.8) 0.264
Constipation 10 (27.1) 7 (10.8) 0.051
Diarrhea 11 (29.7) 16 (24.6) 0.643
Diarrhea
Signs of malabsorption 29 (78.4) 49 (75.4) 0.811
Marsh 3C at diagnosis 17 (45.9) 39 (60) 0.215

* BMI = Body mass index; # Others = Metabolic, cardiovascular; § CD = Celiac disease; ° GI = Gastrointestinal.